氧化纳米药物通过减少炎症和调节ROS来缓解慢性病
Qin Wang1, Xuedan Nie2, Yifan Song1
1Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518000, China. wangqinmail@vip.163.com.
Biomaterials science
|November 11, 2024
概括
这项研究引入了一种新型纳米药物 (Tac@C-Mn3O4 NPs),可以清除活性氧物种 (ROS) 并抑制免疫反应,以保护脏免受慢性脏病 (CKD) 的侵害. 这种纳米药物在治疗损伤方面显示出临床应用的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 免疫介导的淋巴细胞疾病通过免疫细胞过度活化,线粒体功能障碍和反应性氧物种 (ROS) 不平衡导致慢性病 (CKD).
- 氧化应激是多克索鲁比 (DOX) 诱导的CKD病变的一个关键因素.
研究的目的:
- 开发和评估一种超小纳米药物 (Tac@C-Mn3O4 NPs) 用于治疗CKD的老鼠模型中的氧化损伤和免疫失调.
- 为了评估Mn3O4纳米颗粒的功用化酸盐和装载着tacrolimus在恢复功能和结构中的有效性.
主要方法:
- 开发了用酸盐 (C-Mn3O4 NPs) 功能化的超小Mn3O4纳米颗粒,并加载了tacrolimus (Tac).
- 在氧化应激条件下的斯普拉格-道利 (SD) 鼠中建立多克索鲁比 (DOX) 诱导的CKD模型.
- 在体内对ROS清除,免疫抑制作用,线粒体保护和功能恢复的评估.
主要成果:
- Mn3O4纳米颗粒显示出显著的ROS清理能力,模仿酶活性.
- Tac@C-Mn3O4 NPs通过增强透性和保留 (EPR) 效应,在脏区域呈现有针对性的积累,并持续释放药物.
- 该纳米药物保护了线粒体的完整性,减少了促炎性细胞因子,恢复了功能,并通过调节抗氧化应激途径来保持正常的结构.
结论:
- 使用Tac@C-Mn3O4NP的双重治疗策略有效地解决了CKD中的氧化应激和免疫过度激活.
- 这种纳米药物配方显示出在管理免疫媒介质细胞疾病和保持功能方面具有很大的临床转化潜力.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Antihypertensive Drugs: Direct Renin Inhibitors
495
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
495
Enhanced Elimination of Poison
478
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
478


